Paper23949153
The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.
McCowan C and 4 others. Br J Cancer, 2013. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study. Papers, record 23949153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23949153
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Hormonal | Major topic |
| Breast Neoplasms | Major topic |
| Medication Adherence | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Tamoxifen | Major topic |
| Aged | |
| Aged, 80 and over | |
| Cohort Studies | |
| Cost-Benefit Analysis | |
| Female | |
| Humans | |
| Middle Aged | |
| Quality of Life | |
| Quality-Adjusted Life Years | |
| Registries |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12586795 | Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12586795 | PubMed |
| 2 | 12424066 | Tamoxifen non-compliance: does it matter? | Lancet Oncol | 2002 | https://conductscience.org/library/papers/12424066 | PubMed |
| 3 | 17592673 | Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer. | Clin Breast Cancer | 2007 | https://conductscience.org/library/papers/17592673 | PubMed |
| 4 | 1607900 | Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. | J Clin Epidemiol | 1992 | https://conductscience.org/library/papers/1607900 | PubMed |
| 5 | 20803066 | Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. | Breast Cancer Res Treat | 2011 | https://conductscience.org/library/papers/20803066 | PubMed |
| 6 | 12472329 | Interventions to enhance patient adherence to medication prescriptions: scientific review. | JAMA | 2002 | https://conductscience.org/library/papers/12472329 | PubMed |
| 7 | 20921464 | Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20921464 | PubMed |
| 8 | 20385997 | Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20385997 | PubMed |
| 9 | 18155570 | Mortality impact of less-than-standard therapy in older breast cancer patients. | J Am Coll Surg | 2008 | https://conductscience.org/library/papers/18155570 | PubMed |
| 10 | 23519057 | Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. | Br J Cancer | 2013 | https://conductscience.org/library/papers/23519057 | PubMed |
| 11 | 21802721 | Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. | Lancet | 2011 | https://conductscience.org/library/papers/21802721 | PubMed |
| 12 | 17717337 | NICE's cost effectiveness threshold. | BMJ | 2007 | https://conductscience.org/library/papers/17717337 | PubMed |
| 13 | 18985046 | Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18985046 | PubMed |
| 14 | 20058066 | Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis. | Breast Cancer Res Treat | 2010 | https://conductscience.org/library/papers/20058066 | PubMed |
| 15 | 20585090 | Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20585090 | PubMed |
| 16 | 18071188 | Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. | J Clin Oncol | 2008 | https://conductscience.org/library/papers/18071188 | PubMed |
| 17 | 21450800 | Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. | BMJ | 2011 | https://conductscience.org/library/papers/21450800 | PubMed |
| 18 | 10204197 | Multiple imputation of missing blood pressure covariates in survival analysis. | Stat Med | 1999 | https://conductscience.org/library/papers/10204197 | PubMed |
| 19 | 17243168 | Early discontinuation of tamoxifen: a lesson for oncologists. | Cancer | 2007 | https://conductscience.org/library/papers/17243168 | PubMed |
| 20 | 18809051 | Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients. | Am J Surg | 2008 | https://conductscience.org/library/papers/18809051 | PubMed |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42732184 | Exploring trial acceptability, recruitment, and retention in a pilot optimisation randomised controlled trial of a behavioural intervention to support medication adherence in women with breast cancer: A qualitative process evaluation. | NIHR Open Res | 2026 | https://conductscience.org/library/papers/42732184 | PubMed |
| 42108483 | Optimising a behavioural intervention to support endocrine therapy adherence for women with breast cancer: protocol for the ROSETA optimisation factorial randomised controlled trial. | Trials | 2026 | https://conductscience.org/library/papers/42108483 | PubMed |
| 41387699 | Mediators of the association between psychological distress and mortality in people diagnosed with cancer. | Nat Commun | 2025 | https://conductscience.org/library/papers/41387699 | PubMed |
| 41303890 | Adherence and Compliance with Endocrine Treatment After Primary Breast Cancer Treatment: A Cross-Sectional Qualitative Study. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/41303890 | PubMed |
| 41299751 | Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer. | Trials | 2025 | https://conductscience.org/library/papers/41299751 | PubMed |
| 40998714 | Management of menopausal symptoms following treatment for hormone receptor positive breast cancer. | Br J Gen Pract | 2025 | https://conductscience.org/library/papers/40998714 | PubMed |
| 40660375 | A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial. | Pilot Feasibility Stud | 2025 | https://conductscience.org/library/papers/40660375 | PubMed |
| 40356465 | Acceptability of acceptance and commitment therapy for medication-decision-making and quality of life in women with breast cancer: A qualitative process evaluation. | Br J Health Psychol | 2025 | https://conductscience.org/library/papers/40356465 | PubMed |
| 40093412 | Psychometric properties of instruments for assessing adherence to oral antineoplastic agents: a COSMIN systematic review. | PeerJ | 2025 | https://conductscience.org/library/papers/40093412 | PubMed |
| 40052001 | Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston Area. | Patient Prefer Adherence | 2025 | https://conductscience.org/library/papers/40052001 | PubMed |
| 39887069 | Supporting endocrine therapy adherence in women with breast cancer: findings from the ROSETA pilot fractional factorial randomized trial. | Ann Behav Med | 2025 | https://conductscience.org/library/papers/39887069 | PubMed |
| 39742356 | How to Optimize Deimplementation of Sentinel Lymph Node Biopsy? | Breast J | 2024 | https://conductscience.org/library/papers/39742356 | PubMed |
| 39682191 | Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682191 | PubMed |
| 39657026 | Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with breast cancer. | Transl Behav Med | 2025 | https://conductscience.org/library/papers/39657026 | PubMed |
| 39642329 | Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy. | JCO Clin Cancer Inform | 2024 | https://conductscience.org/library/papers/39642329 | PubMed |
| 39444481 | The Impact of Multidisciplinary Educational Team-Based Clinical Nursing Pathway on the Psychological Resilience, Treatment Adherence, Pain Management and Quality of Life in Cancer Patients. | Iran J Public Health | 2024 | https://conductscience.org/library/papers/39444481 | PubMed |
| 39106031 | Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema. | Ophthalmol Ther | 2024 | https://conductscience.org/library/papers/39106031 | PubMed |
| 39060840 | Acceptability of Four Intervention Components Supporting Medication Adherence in Women with Breast Cancer: a Process Evaluation of a Fractional Factorial Pilot Optimization Trial. | Prev Sci | 2024 | https://conductscience.org/library/papers/39060840 | PubMed |
| 38916761 | Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer. | Support Care Cancer | 2024 | https://conductscience.org/library/papers/38916761 | PubMed |
| 38637603 | Association between trajectories of adherence to endocrine therapy and risk of treated breast cancer recurrence among US nonmetastatic breast cancer survivors. | Br J Cancer | 2024 | https://conductscience.org/library/papers/38637603 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| TENM1 | 10178 | PubTator's text mining | https://conductscience.org/library/genes/10178 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23949153
GET https://conductscience.org/api/papers/v1/23949153/references?page=2